World Medical Association clarifies rules on placebo controlled trials

BMJ 2001; 323 doi: 10.1136/bmj.323.7317.825 (Published 13 October 2001)
Cite this as: BMJ 2001;323:825.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Annabel Ferriman
  1. BMJ

    Clarification on the ethical use of placebo controlled trials was published last week by the World Medical Association following its four day council meeting in France.

    The clarification follows criticism from researchers that when the association revised the Declaration of Helsinki last year, its guidance on clinical trials was impractical for researchers in many parts of the world.

    The new ethical standards laid down under the revised declaration stated that the testing of drugs should be done against the best current treatment and not against placebo (BMJ …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL